According to Ocuphire Pharma's latest financial reports the company's current EPS (TTM) is 0,86ย โฌ. In 2022 the company made an earnings per share (EPS) of 0,78ย โฌ an increase over its 2021 EPS that were of -4,51ย โฌ.